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Abstract
Background
Patient empowerment has gained considerable importance but uncertainty remains about
the best way to define and measure it. The validity of empirical findings depends on the
quality of measures used. This systematic review aims to provide an overview of studies as-
sessing psychometric properties of questionnaires purporting to capture patient empower-
ment, evaluate the methodological quality of these studies and assess the psychometric
properties of measures identified.
Methods
Electronic searches in five databases were combined with reference tracking of included ar-
ticles. Peer-reviewed articles reporting psychometric testing of empowerment measures for
adult patients in French, German, English, Portuguese and Spanish were included. Study
characteristics, constructs operationalised and psychometric properties were extracted.
The quality of study design, methods and reporting was assessed using the COSMIN
checklist. The quality of psychometric properties was assessed using Terwee’s
2007 criteria.
Findings
30 studies on 19 measures were included. Six measures are generic, while 13 were devel-
oped for a specific condition (N=4) or specialty (N=9). Most studies tested measures in En-
glish (N=17) or Swedish (N=6). Sample sizes of included studies varied from N=35 to
N=8261. A range of patient empowerment constructs was operationalised in included mea-
sures. These were classified into four domains: patient states, experiences and capacities;
patient actions and behaviours; patient self-determination within the healthcare relationship
and patient skills development. Quality assessment revealed several flaws in methodologi-
cal study quality with COSMIN scores mainly fair or poor. The overall quality of psychometric
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properties of included measures was intermediate to positive. Certain psychometric proper-
ties were not tested for most measures.
Discussion
Findings provide a basis from which to develop consensus on a core set of patient empow-
erment constructs and for further work to develop a (set of) appropriately validated measure
(s) to capture this. The methodological quality of psychometric studies could be improved
by adhering to published quality criteria.
Introduction
Patient empowerment is gaining greater international importance in healthcare [1]. Reflecting
the shift in Western culture towards increasing consumerism and individualism, institutional
culture in healthcare is slowly moving away from an ethic of paternalism towards an ethic of
empowering patients to make informed decisions. This is demonstrated by interest in develop-
ing and implementing more equitable and collaborative approaches to the healthcare relation-
ship, including shared decision-making [2–5]. There is some limited evidence that patient
empowerment can improve cost-effective use of health services [1]. Self-care interventions for
long-term conditions, sometimes called patient empowerment programmes, have been shown
to improve mental health, doctor-patient communication, healthy eating, and patient self-effi-
cacy [6,7], although the capacity of existing outcome measures to capture the patient benefits
of these programmes has been questioned [8].
In the UK, government health policy declared in “High Quality Care for All” [9] committed
the National Health Service (NHS) to patient empowerment. Since then, initiatives designed to
provide NHS patients with greater choice and control over their own healthcare have been de-
veloped and implemented, for example Personal Health Budgets and Personalised Care Plans.
Furthermore, following the 2011 Health & Social Care Bill in England, there are moves to link
NHS funding to performance against a range of existing and new quality measures that include
patient reported outcome measures (PROMs). Similarly, in the USA, the quality of patient cen-
tered care, including patient empowerment, may soon be linked to remuneration and im-
proved legal protection for healthcare professionals [10,11].
However, despite this, there is no agreement about the best way to demonstrate that patients
have, indeed, been empowered. The concept of patient empowerment has not been consistently
operationalised because there is no consensus about how the term should be defined [12].
There is no universally accepted measure of patient empowerment that can be used to evaluate
and compare patient empowerment initiatives across different healthcare services, although
some quite generic patient empowerment measures have been published recently [13,14]. A
number of condition-specific and specialty-specific patient empowerment measures have also
been published, for example, the Empowerment Scale (mental health) [15], the Diabetes
Empowerment Scale [16], the Patient Empowerment Scale (cancer) [17] and the Genetic
Counselling Outcome Scale (clinical genetics) [18]. A 2009 systematic review of questionnaires
measuring health-related empowerment identified 50 questionnaires purporting to measure
health-related empowerment, and rated these in terms of reliability and validity [19]. This re-
view did not assess the methodological quality of the included studies, provided only a limited
assessment of the psychometric properties of included measures [20–25], and included mea-
sures that were intended for completion by non-patients, e.g. parents or family members.
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A brief review of self-report questionnaires capturing patient empowerment to date suggests
that available measures in this area have been developed independently, with scale content in-
formed by different theoretical frameworks [12]. The constructs captured by measures in this
brief review were not the same, although there are some areas of identifiable theoretical overlap
across some of these measures that relate to decision-making, control and self-efficacy [12].
We do not know at present whether this is because different constructs are important for dif-
ferent conditions, or because they were developed independently without a generic theoretical
framework of patient empowerment for guidance. This apparent heterogeneity across mea-
sures of patient empowerment means that approaches, interventions and policies designed to
empower patients in healthcare cannot be evaluated on the basis of how effective they are at
achieving this goal because the goal itself is not clear, and there is little agreement about how to
measure it.
Given both the interest in patient empowerment and the need for high quality patient re-
ported measurement, we set out to conduct a systematic review with a focus on patient-re-
ported measures of patient empowerment that could be used as PROMs. This review is the first
to apply current published methodological standards for conducting systematic reviews of
measurement instruments [22,24,26] and guidelines to assess the psychometric properties of
the identified measures of patient empowerment [23]. The key aims of our review were as fol-
lows: to identify measures of patient empowerment that have been developed and psychometri-
cally tested; to assess the quality of existing patient empowerment measures; and finally to
describe the conceptual domains captured by existing measures of patient empowerment.
Methods
1. Protocol and registration
The protocol for this systematic review was registered on PROSPERO: http://www.crd.york.ac.
uk/PROSPERO/display_record.asp?ID=CRD42013003961#.U2zSMWcU-L0
2. Eligibility criteria
Peer-reviewed studies that reported the psychometric properties of a patient reported measure
or PROM that assessed patient empowerment were retrieved. The aim was to include measures
of patient empowerment and measures of related constructs, including enablement, activation,
perceived control, capability and independence. To be included, the measure had to have been
tested in a sample of adult patients in a healthcare setting and one aim of the study had to be to
assess psychometric properties of the measure. Articles in English, French, German, Portu-
guese and Spanish were all retrieved. Studies that lacked a psychometric assessment, were not
tested in a sample of adult patients or were designed for completion by children or other rela-
tives or carers were excluded.
3. Information sources
To achieve a highly sensitive search strategy, databases were searched from their inception to
Sept 15, 2012 using a number of Medical Subject Headings (MeSH) and keywords in four do-
mains: (i) patient (ii) empowerment, (iii) measures and (iv) psychometrics (S1 Fig). Databases
searches were conducted in MEDLINE, EMBASE, Cochrane, Web of Science and ASSIA. A
secondary search of the reference sections of included papers and identified review articles was
also conducted.
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4. Search, study selection, & data collection
The electronic search strategies used are available in S1 Fig Titles and abstracts retrieved from
the database searches were equally distributed to four team members (PB, IS, PBr, MMc) for
independent screening. To ensure screening quality and consistency, the first 15% of each re-
viewer’s titles and abstracts were rescreened by another member of the team with a comparison
of included and excluded titles made; disagreements were resolved by discussion. This ensured
that exclusion criteria were applied consistently for the remaining 85% of titles and abstracts.
The standardised data extraction procedure was first piloted and then implemented by four
members of the study team (PB, IS, PBr, MMc). Data extracted included the study aims, patient
population, setting, purpose and description, including psychometric properties of the patient
reported measure under evaluation.
5. Study quality and risk of bias appraisal
The Center for Reviews and Dissemination (CRD) and the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) recommends the use of checklists to appraise
study quality [6]. We undertook two assessments of quality with two distinct aims: Firstly, to
evaluate the methodological quality of the included studies. This was achieved using the COn-
sensus-based Standards for the selection of health Measurement Instruments (COSMIN) crite-
ria. However, the COSMIN criteria do not provide an assessment of the psychometric
properties of the instruments themselves. To address this, we used criteria developed by Terwee
et al. (2007) [23].
The COSMIN criteria were used to assess methodological quality of the included studies.
The COSMIN checklist evaluates nine psychometric properties (‘A’ through ‘I’: A = internal
consistency, B = reliability; C = measurement error, D = content validity, E = structural validity,
F = hypothesis testing; G = cross-cultural validity, H = criterion validity, I = responsiveness).
Each box comprises items evaluating methodological quality, such as appropriateness of sample
size and psychometric statistic(s) generated. Each COSMIN item can be rated as ‘Excellent’,
‘Good’, ‘Fair’ or ‘Poor’, with a description provided for how to attribute a rating to each COS-
MIN item. An additional box was used to assess requirements for studies that used Item Re-
sponse Theory (IRT). Interpretability and generalisability were also assessed for each of the ten
boxes that investigated methodological quality.
To apply the COSMIN criteria four steps were followed: 1) Identify what properties (boxes)
were assessed in the paper and select these boxes, 2) determine if classical test theory (CTT) or
IRT was used, 3) evaluate methodological quality of studies identified in step 1 and 4) assess
the generalisability of results from the studies on properties identified in step 1. Further details
of how the COSMIN criteria are applied are available online at http://www.cosmin.nl/. The
‘worst score count’ is the method of assessment for COSMIN boxes A to I, i.e. the lowest rating
on an item from any one box was considered the overall score for that box. Therefore where
the majority of items within the box are considered ‘good’, and one item is marked as ‘fair’ the
overall quality of that box is considered ‘fair’. For COSMIN criteria, the overall proportion of
included studies that achieved a rating of ‘Excellent’, ‘Good’, ‘Fair’ or ‘Poor’, is presented for
each methodological element (box) examined. For interpretability and generalisability boxes
there is no possibility to aggregate the extracted data into a sum score, therefore these sections
will be summarised qualitatively.
Criteria developed by Terwee et al [23] to appraise the psychometric quality of question-
naires were used to assess the quality of the measures identified in this study. Criteria assessed
were: internal consistency, content validity, criterion validity, construct validity, reproducibili-
ty, responsiveness, floor and ceiling effects and interpretability. Items were rated as positive ‘+’,
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intermediate ‘?’, negative ‘-‘, or no information ‘ _ ‘ (Further detail in Terwee et al [23]). The
authors [23] suggest presenting the results in the form of a table rather using an ‘overall quality
score’. Such a score would assume equal importance for each psychometric property, which in
practice is not the case. In addition, as recommended by Terwee et al [23] criterion validity was
not assessed in this study using either COSMIN or Terwee et al criteria because there is no gold
standard comparison for measures of patient empowerment.
At the full paper screen, the included articles were again distributed equally to four team
members (PB, IS, PBr and MMc) for assessment of the methodological quality of studies and
the quality of included measures. To ensure consistency in application of the COSMIN criteria,
a fifth team member (MF) independently applied the COSMIN criteria to a random sample of
25% of included papers at the start of data extraction. Any disagreements were resolved
through team discussion prior to extracting data for the remaining 75% of articles. One of the
included studies was conducted by the senior author (MMc). To avoid any intellectual conflict
of interest, this study was neither extracted nor rated by MMc.
6. Data analysis and synthesis of results
The key characteristics of the studies and the quality of the studies were combined in a narra-
tive summary and tabulated according to CRD guidelines [27]. In addition, the key constructs
(subscales, or definitions where subscales were not reported) measured by each PROMwere re-
corded and these were analysed to identify general themes that emerged regarding constructs
captured by the included measures of patient empowerment.
Results
1. Included studies
Electronic searches identified 4083 records and the secondary search generated 311 additional
records. After removing duplicates, 3836 records remained. Title and abstract screening re-
sulted in exclusion of 3662 records. The remaining 174 full-text articles were retrieved and as-
sessed for eligibility. The original aim had been to identify measures of patient empowerment,
enablement, activation, perceived control, capability and independence. However, following
identification of full-text articles, a decision was made to include only measures that specifically
stated that they were designed to measure patient empowerment. Focusing only on measures
that purport to capture patient empowerment enabled more clarity to be provided regarding
the constructs used to operationalise patient empowerment and removed the ambiguity of in-
cluding related, but subtly different constructs. This led to the inclusion of 30 studies. The
main reasons for exclusion were that the measure did not purport to capture a construct called
patient empowerment (N = 72) or was not tested in a sample of adult patients (N = 35). The 72
measures excluded because they captured other constructs included 12 measures capturing pa-
tient enablement, 16 measures capturing patient activation, 27 measures capturing perceived
control and 17 measures capturing other constructs. No articles were identified by the search
strategy that captured either capability or independence. Fig 1 provides the study PRISMA
flow chart with the complete list of reasons for exclusion at the stage of eligibility assessment.
2. Overview of studies
Table 1 gives an overview of included measures and Table 2 provides an overview of included
studies. In total 30 studies were included in the review, reporting on 19 different measures.
Fourteen measures were developed specifically to assess patient empowerment and in five mea-
sures patient empowerment was included as one subscale of a larger questionnaire. Six
Systematic Review of Patient Empowerment Measures
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measures are generic, while the other 13 were developed for a specific condition (N = 4) or to
be used within a specific specialty (N = 9). Half of the studies (N = 15) were reporting on initial
development and validation of the measure, and the rest were reporting on further develop-
ment (including translation) of an existing measure. Some studies reporting initial develop-
ment of a measure were excluded (e.g. Empowerment Scale (mental health)) because the initial
development and validation study did not test the measure with patients [15]. However, studies
further developing the measure with patient samples are included. Ten of the studies were
from the US, six from Sweden, four from the UK, three from China, three from Australia, and
one each from Japan, Italy, Iran and Iceland. Most studies reported on the validation of mea-
sures in English (N = 17) or Swedish (N = 6). The number of items in included measures ran-
ged from 5 to 42 items. Of the 19 measures, ten use a five-point Likert scale for response
categories. Sample sizes of the studies vary from N = 35 to N = 8261 patients. Conditions affect-
ing the patients included in the test samples varied, with several studies conducted with sam-
ples of patients affected by a mental health condition (N = 10) [28–37] or diabetes (N = 7)
[16,38–43].
Fig 1. PRISMA flow chart of study selection.
doi:10.1371/journal.pone.0126553.g001
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Table 1. Overview of includedmeasures.
Measure (Author) Target
population
Items Sub-scales Response
scale
Language*
Patient Empowerment Scale #1—
Original (Faulkner, 2001) [13]
All patients
(generic)
40 No subscales reported; designed to capture
feelings of control in hospital environments
catering for older people by asking about
empowering and disempowering behaviours of
hospital staff
3-Point Likert
Scale
English
Kim Alliance Scale—Original (Kim et al,
2001) [46]
All patients
(generic)
30 Four subscales: Collaboration, Communication,
Integration, Empowerment
4-Point Likert
Scale
English
Kim Alliance Scale—Revised (Kim et al,
2008) [47]
All patients
(generic)
16 Four subscales: Collaboration, Communication,
Integration, Empowerment
4-Point Likert
Scale
English
Treatment Related Empowerment Scale
(TES)—Original (Webb et al, 2001) [45]
All patients
(generic)
10 Four subscales: Choice, Decision making,
Communication, Satisfaction
5-Point Scale English
Health Education Impact Questionnaire
(HEIQ)—Original (Osborne et al, 2007)
[44]
All patients
(generic)
42 Eight subscales: Positive active engagement in
life, Health directed behavior, Skill & technique
acquisition, Constructive attitudes & approaches,
Self-monitoring & insight, Health services
navigation, Social integration & support, Emotional
wellbeing
Not speciﬁed English
Scale developed by Bann et al.—
Original (Bann et al, 2010) [49]
All patients
(generic)
5 No subscales reported (Aim was to create three
scales: Perceived provider support, Patient-
centered care (PCC) and Empowerment)
3-Point Scale English
Health Care Empowerment Inventory
(HCEI)—Original (Johnson et al, 2012)
[52]
All patients
(generic)
8 Two subscales: HCE ICCE: informed, committed,
collaborative & engaged, HCE TU: tolerance for
uncertainty
5-Point Likert
Scale
English
Empowerment Scale—Original (Wowra
& McCarter, 1999) [29]
Mental health
patients
28 Five subscales: Self-esteem & self-efﬁcacy,
Optimism & control over the future, Power &
powerlessness, Activism & autonomy, Righteous
anger
4-point Likert
Scale
English
Japanese
Swedish
Empowerment Scale—Version 2
(Corrigan et al. 1999) [36]
Mental health
patients
25 Two super-ordinate factors: (i) Self-orientation:
three sub-scales: Self-esteem, Self-efﬁcacy,
Optimism (ii) Community orientation: three sub-
scales: Community action, Powerlessness,
Effecting change
4-point Likert
Scale
English
Health Promotion Intervention
Questionnaire—Original (Svedberg
et al, 2007) [33]
Mental health
patients
19 Four subscales: Alliance, Empowerment,
Educational support, Practical support
5-Point Likert
Scale
Swedish
Empowerment Questionnaire for
Inpatients (EQuIP)—Original (Lopez
et al, 2010) [37]
Mental health
patients
16 No subscales reported (Expected sub-scales were
information, choice, and communication, but CFA
did not conﬁrm this and EFA was not conducted)
4-Point Likert
Scale
English
Consumer Evaluation Of Mental Health
Services (CEO-MHS)—Original (Oades
et al, 2011) [34]
Mental health
patients
26 Two subscales: Empowerment (consumers’ sense
of control over their illness, treatment and stigma),
Dehumanization
5-Point Likert
Scale
English
Inpatient Consumer Survey—Original
(Ortiz & Schacht, 2012) [35]
Mental health
patients
28 Six subscales: Outcome, Dignity, Rights,
Participation, Environment, Empowerment (patient
choice & communication)
5-Point Likert
Scale
English
Diabetes Empowerment Scale—
Original (Anderson et al, 2000) [16]
Diabetes
patients
28 Three subscales: Managing the psychosocial
aspects of diabetes, Assessing dissatisfaction &
readiness to change, Setting & achieving diabetes
goals
5-Point Likert
Scale
English
Icelandic
Persian
Diabetes Empowerment Scale—
Version 2 (Shiu et al, 2003) [39]
Diabetes
patients
20 Five subscales: Overcoming barriers, Determining
suitable methods, Achieving goals, Obtaining
support, Coping
5-Point Likert
Scale
Chinese
Diabetes Empowerment Scale—
Version 3 (Leksell et al, 2007) [38]
Diabetes
patients
23 Four subscales: Goal achievement, Self
awareness, Stress management, Readiness to
change
5-Point Likert
Scale
Swedish
(Continued)
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3. Constructs captured by included measures
Details of the subscales used to capture patient empowerment were extracted from the included
articles (See Table 1). Six articles did not report any subscales; for these, we have included some
information on what the measure was intended to capture. Constructs captured by the includ-
ed articles illustrate a diversity of conceptualisations of patient empowerment, captured by a
wide range of different subscales (See Tables 1 & 3).
There was no clear consensus across the included articles about what patient empowerment
comprises. Each included measure captured a different conceptualisation of patient empower-
ment, with approximately 38 distinct constructs identifiable. A synthesis of constructs captured
by the included measures is shown in Table 3, grouped into four domains. Constructs ranged
from patient empowerment conceptualised as:
Domain 1: Patient states, experiences and capacities (21 constructs)
Domain 2: Patient actions and behaviours (11 constructs)
Domain 3: Patient self-determination within the healthcare relationship (four constructs)
Table 1. (Continued)
Measure (Author) Target
population
Items Sub-scales Response
scale
Language*
Chinese Diabetes Empowerment
Process Scale (C-DEPS)—Original
(Chen et al, 2011) [43]
Diabetes
patients
15 Four subscales: Mutual participation, Raising
awareness, Providing necessary information,
Open communication
5-Point Likert
Scale
Chinese
Patient Empowerment Scale #2—
Original (Bulsara et al, 2006) [17]
Cancer
patients
28 No subscales reported; designed to capture ability
to accept illness, develop coping strategies, regain
a sense of control
4-Point Likert
Scale
English
Cyber Info-Decisional Empowerment
Scale (CIDES)—Original (Seckin, 2011)
[53]
Cancer
patients
7 No Subscales reported (Aim was to capture extent
to which cyber-information provide knowledge
about cancer, treatment & whether to obtain
second opinion; informs about research and health
services; facilitates decision-making regarding
treatment)
5-Point Likert
Scale
English
Genetic Counseling Outcome Scale—
Original (McAllister et al, 2011) [18]
Clinical
genetics
patients
24 No Subscales reported (Aim was to create ﬁve
subscales: cognitive control, decisional control,
behavioural control, emotional regulation, hope for
the future; EFA performed but unstable)
7-Point Likert
Scale
English
Parents’ Postnatal Sense of Security
(PPSS)—Mother version—Original
(Persson et al, 2007) [48]
Postnatal care
patients
18 Four subscales: Sense of midwifes'/nurses'
empowering behavior, Sense of general wellbeing,
Sense of afﬁnity with the family, Sense that breast
feeding was manageable
4-Point Likert
Scale
Swedish
Parents’ Postnatal Sense of Security
(PPSS)—Father Version—Original
(Persson et al, 2007) [48]
Postnatal care
patients
13 Four subscales: Sense of midwifes'/nurses'
empowering behavior, Sense of the mother's
general wellbeing including breast feeding, Sense
of afﬁnity with the family, Sense of general
wellbeing
4-Point Likert
Scale
Swedish
Psoriasis Empowerment Enquiry in the
Routine practice questionnaire (PEER)
—Original Pagliarello et al (2010) [50]
Psoriasis
patients
12 Three subscales: Knowledge, Experience, Skills 5-Point Likert
Scale
Italian
The Swedish Rheumatic Disease
Empowerment Scale (SWE-RES-23)—
Original (Arvidsson et al, 2012) [51]
Rheumatic
disease
patients
23 5 Subscales: Goal achievement & overcoming
barriers to goal achievement, Self-knowledge,
Managing stress, Assessing dissatisfaction &
readiness to change, Support for caring
5-Point Likert
Scale
Swedish
* Language of measures used by included studies.
doi:10.1371/journal.pone.0126553.t001
Systematic Review of Patient Empowerment Measures
PLOS ONE | DOI:10.1371/journal.pone.0126553 May 13, 2015 8 / 24
Table 2. Characteristics of included studies.
Author (year), Scale (target population) Country Study population Sample characteristics
Faulkner (2001) [13], Patient Empowerment
Scale # 1 (All patients, generic)
UK Older hospitalized people Pre-test sample: n = 78; main sample: n = 102
Kim et al. (2001) [46], Kim Alliance Scale
(KAS) (All patients, generic)
USA Nurses as patients n = 68
Kim et al. (2008) [47], Kim Alliance Scale
Revised (KAS-R) (All patients, generic)
USA Patients of two outpatient clinics
serving military family members and
retirees
Sample 1: n = 304, 21% male, mean age 39.2
years, SD 12.8; Sample 2: n = 297, 20% male,
mean age 40.7 years, SD 12.6
Webb et al. (2001) [45], Treatment Related-
Empowerment Scale (TES) (All patients,
generic)
UK Patients with advanced HIV n = 43, 93% male, mean age 39.6 years, SD 7.7
Osborne et al. (2007) [44], Health Education
Impact Questionnaire (HEIQ) (All patients,
generic)
Australia Both samples had a wide range of
chronic diseases
Sample 1: members of the Arthritis foundation,
n = 591, 84% female, mean age 62, SD 13; Sample
2: broader population, n = 598, 58% female, mean
age 61, SD 14
Bann et al. (2010) [49], Scale developed by
Bann et al. (2010) (All patients, generic)
USA Patients with various health problems
receiving complementary and
alternative medicine (CAM)
Pre-test sample: n = 44; main sample: n = 216, 85%
female, age: 29% < 44, 28% 45–54, 43% > 54
Johnson et al. (2012) [52], Health Care
Empowerment Inventory (HCEI) (All patients,
generic)
USA HIV infected patients Sample 1: n = 275, 100% male, mean age 46.9, SD
9.6; Sample 2: n = 370, 78.2% male, mean age,
45.2, SD 8.2
Wowra & McCarter (1999) [29],
Empowerment Scale version 1 (Mental health
patients)
USA Outpatients of mental health services n = 283, 67% female, age 62% range 36 55
Corrigan et al. (1999) [36], Empowerment
Scale version 2 (Mental health patients)
USA Consumers of a university partial
hospitalization program, all with a
diagnosis of severe mental illness
n = 35, 35.1% female, mean age 33.1 years, SD 9.2
Hansson & Bjorkman (2005) [28],
Empowerment Scale version 1 (Mental health
patients)
Sweden Patients with severe mental illnesses n = 92, 53% female, mean age 47 years, range 29–
68
Yamada & Kuzuki (2007) [31], Empowerment
Scale version 1 (Mental health patients)
Japan Patients with chronic schizophrenia n = 72, 40% female, mean age 41.7 years, SD 10.7
Rogers et al. (2010) [30], Empowerment
Scale version 1 (Mental health patients)
USA Consumers of mental health services
with a diagnosis of severe mental
disorder
n = 1827, 64% female, mean age 41 years, range
18–72
Svedberg et al. (2007)* [33], Health
Promotion Intervention Questionnaire (Mental
health patients)
Sweden Patients in contact with mental health
services
n = 135, 64% female, mean age 41 years, range
18–72
Svedberg et al. (2008)* [32], Health
Promotion Intervention Questionnaire (Mental
health patients)
Sweden Patients in contact with mental health
services
Pre-test sample: n = 31; main sample: n = 135,
64.4% female, mean age 41 years, range 18–72
Lopez et al. (2010) [37], Empowerment
Questionnaire for Inpatients (EQuIP) (Mental
health patients)
UK Patients older than 65 years with a
functional psychiatric diagnosis
n = 87, 61% female, mean age 73.7 years, SD 5.9,
range 65–87
Oades et al. (2011) [34], Consumer
Evaluation Of Mental Health Services
(CEO-MHS) (Mental health patients)
Australia Mental health services consumers n = 202, 49% female, mean age 40.9 years, SD
13.06, range 16–83
Ortiz & Schacht (2012) [35], Inpatient
Consumer Survey (Mental health patients)
USA Individuals receiving psychiatric care Sample 1: n = 8229, 65% male, 78% aged between
18–54 years; Sample 2: n = 8261, 65% male, 78%
aged between 18–54 years
Anderson et al. (2000) [16], Diabetes
Empowerment Scale version 1 (Diabetes
patients)
USA Type 1 or 2 diabetes patients n = 375, 45% male, mean age 50.4 years, SD 15.8
Shiu et al. (2003) [39], Diabetes
Empowerment Scale version 2 (Diabetes
patients)
China Type 1 or 2 diabetes patients Pre-test sample: n = 31; main sample: n = 207,
52.2% female, mean age 53 years, SD 12.4
(Continued)
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Domain 4: Patient skills development (two constructs).
Fifteen constructs were captured by one measure only. Another 14 constructs were captured
by at least one generic measure and at least one specialty or condition-specific measure.
4. Quality of design, methods and reporting
Table 4 provides an overview of the assessment of the methodological quality of included studies
using the COSMIN criteria [22,24,26]. Detailed results for the COSMIN checklist with 4-point
scale ratings are shown in S1 Table. While most studies used classical test theory (CTT), one
study used item response theory (IRT) [17] and one used both CTT and IRT [44]. Only one
study earned a rating of excellent on an aspect of methodological quality [34]. Included studies
assessed a median of four out of the nine COSMIN criteria. Across the included measures only
Table 2. (Continued)
Author (year), Scale (target population) Country Study population Sample characteristics
Shiu et al. (2006)[40], Diabetes
Empowerment Scale version 2 (Diabetes
patients)
China Type 1 or 2 diabetes patients n = 189, 49% male, mean age 52.26 years, SD
12.43
Leksell et al. (2007)[38], Diabetes
Empowerment Scale version 3 (Diabetes
patients)
Sweden Type 1 or 2 diabetes patients n = 195, 51.6% male, mean age 59.4 years, range
22–90
Sigurdardottir & Jonsdottir (2008)[41],
Diabetes Empowerment Scale version 1,
(Diabetes patients)
Iceland Diabetes patients n = 90, 53.3% female, mean age 38.11 years, SD
11.11
Tol et al. (2012)[42], Diabetes Empowerment
Scale version 1 (Diabetes patients)
Iran Type 2 diabetes patients Pre-test sample: n = 14; main sample: n = 160,
72.9% female, mean age 50.23 years, SD 11.0,
range 19–83
Chen et al. (2011) [43], Chinese Diabetes
Empowerment Process Scale (C-DEPS)
(Diabetes patients)
China Type 1 or 2 diabetes patients Pre-test sample: n = 20; main sample: n = 211,
50.2% female, mean age 59.3 years, SD 13.4,
range 20–87
Bulsara et al. (2006) [17], Patient
Empowerment Scale (PES) # 2 (Cancer
patients)
Australia Cancer patients n = 113
Seckin (2011) [53], Cyber Info-Decisional
Empowerment Scale (CIDES) (Cancer
patients)
USA Cancer patients n = 350, 72.9% female, mean age 50.23 years, SD
11.0, range 19–83
McAllister et al. (2011) [18], Genetic
Counseling Outcome Scale (Clinical genetics
patients)
UK Patients with genetic conditions Sample 1: n = 527, 79.5% female, 35.2% aged 17–
40 years; 33.4% aged 40–49 years; 31.4% aged
50–80 years; Sample 2: n = 395, 74.4% female, age
range 18–79
Persson et al. (2007) [48], Parents’ Postnatal
Sense of Security (PPSS) (Postnatal care
patients)
Sweden Parents 1 week post child birth Sample 1: n = 113 mothers, mean age 29.8 years;
Sample 2: n = 99 fathers, mean age 32.4 years
Pagliarello et al. (2010) [50], Psoriasis
Empowerment Enquiry in the Routine
practice questionnaire (PEER) (Psoriasis
patients)
Italy Psoriasis patients n = 223, 50.7% female, mean age 45.5 years, SD
15.5
Arvidsson et al. (2012) [51], The Swedish
Rheumatic Disease Empowerment Scale
(SWE-RES-23) (Rheumatology patients)
Sweden Patients with rheumatic diseases Pre-test sample: N = 58; main sample: n = 260, 75%
female, mean age 54 years
SD = standard deviation
* The two papers on the Health Promotion Intervention Questionnaire report on different research questions (assessment of different psychometric
properties) of the same study (same sample size)
# We found two measures named Patient Empowerment Scale that are not related to each other
doi:10.1371/journal.pone.0126553.t002
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Table 3. Domains captured across generic and condition- or specialty-specific measures.
Measure (target population) Domain 1 Patient states,
experiences and
capacities
Domain 2 Patient
actions and
behaviours
Domain 3 Patient self-
determination within the
healthcare relationship
Domain 4
Developing
patient skills
*Patient Empowerment Scale # 1 [13] (All
patients, generic)
+ - - -
Kim Alliance Scale [46,47] (All patients,
generic)
+ + + -
Treatment Related-Empowerment Scale
(TES) [45] (All patients, generic)
+ - + -
Health Education Impact Questionnaire
[44] (All patients, generic)
+ + - +
*Scale developed by Bann et al. (2010)
[49] (All patients, generic)
+ + + +
Health Care Empowerment Inventory
(HCEI) [52] (All patients, generic)
+ - + -
Empowerment Scales (Original) [28–31]
(Mental health patients)
+ + - -
Empowerment Scales (Version 2) [36]
(Mental health patients)
+ + - -
Health Promotion Intervention
Questionnaire [32,33] (Mental health
patients)
- - + -
*Empowerment Questionnaire for
Inpatients (EQuIP) [37] (Mental health
patients)
+ - + -
Consumer Evaluation Of Mental Health
Services (CEO-MHS) Scale [34] (Mental
health patients)
+ - - -
Inpatient Consumer Survey (Mental health
patients)
- - + -
Diabetes Empowerment Scale (Original)
[16,41,42] (Diabetes patients)
+ + - -
Diabetes Empowerment Scale (Version 2)
[39,40] (Diabetes patients)
+ + - -
Diabetes Empowerment Scale (Version 3)
[38] (Diabetes patients)
+ + - -
Chinese Diabetes Empowerment Process
Scale (C DEPS) [43] (Diabetes patients)
+ - + -
*Patient Empowerment Scale #2 [17]
(Cancer patients)
+ - - -
*Cyber Info-Decisional Empowerment
Scale (CIDES) [53] (Cancer patients)
+ - + -
*Genetic Counseling Outcome Scale [18]
(Clinical Genetics patients)
+ - - -
Parents’ Postnatal Sense of Security
(PPSS) [48] (Postnatal patients)
+ - + -
Psoriasis Empowerment Enquiry in the
Routine practice questionnaire (PEER)
[50] (Psoriasis patients)
+ - - +
(Continued)
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an average of three psychometric properties, of the nine possible psychometric properties, were
assessed, of which only one, on average, received a positive score. All but three studies [31,33,36]
reported internal consistency and could be rated using COSMIN box A. Ratings for internal con-
sistency were either poor [13,17,18,28,30,34,35,37,41,44,45] or fair [16,29,32,38–40,42,43,46–53].
Reliability (box B) was only assessed in six studies, either resulting in poor [32,37,39] or fair rat-
ings [18,36,43]. Measurement error was not reported in any study and could therefore not be
rated with COSMIN box C. Content validity (box D) was assessed by most studies with a high
variability of scores, ranging from several studies rated as poor [13,16,28,35,37,38,45–47,49–52]
to one single study rated as excellent [34]. Structural validity (box E) was also assessed by most
studies with only the study on the Genetic Counseling Outcome Scale [18] being rated as good
and all other studies receiving poor [28,30,31,34,36,37,41] or fair ratings [16,17,29,32,35,38–
40,42–44,46–53]. Regarding hypothesis testing (box F) studies were either rated as poor
[16,18,28,30,31,35–38,43,45–47] or fair [29,32,33,39–42,49,51–53]. Testing of cross-cultural va-
lidity (box G) was only applicable for five studies, but was rated poor for three of those studies
[28,38,41] and fair for the other two studies[39,42]. Responsiveness (box I) was only assessed in
one study [18] and was rated as fair.
For interpretability, only four studies reported how missing items were handled
[18,34,35,44]. All four studies excluded responses with more than a minimum percentage of
missing items. Only two of those studies reported methods of imputing responses where there
were fewer than the minimum number of missing values [18,44]. Furthermore, only four stud-
ies reported the percentage of respondents with the highest possible score [38,47,49,51], and
only three studies reported the percentage of respondents with the lowest possible score
[38,41,51]. Similarly almost no studies reported on scores and change scores in sub-groups.
Neither minimal important change (MIC) nor minimal important difference (MID) were as-
sessed in any study.
For generalisability, most studies included patients with a wide age range. Distribution of
sex seems to quite representative across all studies. Most studies were conducted in Western
countries [13,16–18,28–30,32–38,41,44–53]. However, there were also several studies from
Asia [31,39,40,42,43]. The most common sampling method was convenience sampling
Table 3. (Continued)
Measure (target population) Domain 1 Patient states,
experiences and
capacities
Domain 2 Patient
actions and
behaviours
Domain 3 Patient self-
determination within the
healthcare relationship
Domain 4
Developing
patient skills
The Swedish Rheumatic Disease
Empowerment Scale (SWE-RES-23) [51]
(Rheumatology patients)
+ - - -
* Six measures did not report sub-scales. For these measures, the domain(s) captured were inferred by examining the deﬁnition of patient empowerment
that the authors claimed to capture.
Domain 1: Self-efﬁcacy; Self-esteem; Self-conﬁdence; Satisfaction; Stigma; Commitment & engagement; Self-monitoring, self-knowledge & insight/
awareness; Optimism / hope; Perceived (sense of) control; Righteous anger; Acceptance; Enablement; Readiness to change; Power / powerlessness;
Tolerance for uncertainty; Sense of afﬁnity with the family; Motivation to advocate for oneself; Having knowledge / Information / being informed; Emotional
regulation / wellbeing; constructive attitudes and approaches; Autonomy.
Domain 2: Learn from past experience; Positive active engagement with life; Health directed behaviour / manage and improve own health; Health service
navigation; Social integration; Effecting change; Community activism; Coping (strategies including obtaining support); Managing psychosocial aspects of
disease; Setting & achieving disease-related goals (including determining suitable methods and overcoming barriers); Stress management.
Domain 3: Power-sharing/collaboration/mutual participation; Mutual / Patient decision-making; Patient choice / self-determination self; Communication.
Domain 4: Developing skills / skills acquisition; Sense of healthcare providers empowering behaviour.
doi:10.1371/journal.pone.0126553.t003
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Table 4. Quality of design, methods and reporting of studies on psychometric properties (COSMIN ratings).
Measure (target population) Authors (Year) IRT or
CTT
Score
IRT
A B C D E F G I
Patient Empowerment Scale (All patients, generic) Faulkner (2001) [13] CTT 0 0
Kim Alliance Scale (All patients, generic) Kim et al. (2001) [46] CTT + 0 + 0
Kim Alliance Scale Revised (All patients, generic) Kim et al. (2008) [47] CTT + 0 + 0
Treatment-Related Empowerment Scale (All patients,
generic)
Webb et al. (2001) [45] CTT 0 0 0
Health Education Impact Questionnaire (All patients, generic) Osborne et al. (2007) [44] CTT &
IRT
++ 0 + +
No name (Scale developed by Bann et al) (All patients,
generic)
Bann et al. (2010) [49] CTT + 0 + +
Health Care Empowerment Inventory (All patients, generic) Johnson et al. (2012) [52] CTT + 0 + +
Empowerment Scale version 1 (Mental health patients) Wowra & McCarter (1999) [29] CTT + + +
Empowerment Scale version 1 (Mental health patients) Hansson & Bjorkman (2005)
[28]
CTT 0 0 0 0 0
Empowerment Scale version 1 (Mental health patients) Yamada & Kuzuki (2007) [31] CTT 0 0
Empowerment Scale version 1 (Mental health patients) Rogers et al. (2010) [30] CTT 0 0 0
Empowerment Scale version 2 (Mental health patients) Corrigan et al. (1999) [36] CTT + 0 0
Health Promotion Intervention Questionnaire (Mental health
patients)
Svedberg et al. (2007) [33] CTT +
Health Promotion Intervention Questionnaire (Mental health
patients)
Svedberg et al. (2008) [32] CTT + 0 + + +
Empowerment Questionnaire for Inpatients (Mental health
patients)
Lopez et al. (2010) [37] CTT 0 0 0 0 0
Consumer Evaluation Of Mental Health Services (Mental
health patients)
Oades et al. (2011) [34] CTT 0 ++
+
0
Inpatient Consumer Survey (Mental health patients) Ortiz & Schacht (2012) [35] CTT 0 0 + 0
Diabetes Empowerment Scale version 1 (Diabetes patients) Anderson et al. (2000) [16] CTT + 0 + 0
Diabetes Empowerment Scale version 1 (Diabetes patients) Sigurdardottir & Jonsdottir
(2008) [41]
CTT 0 ++ 0 + 0
Diabetes Empowerment Scale version 1 (Diabetes patients) Tol et al. (2012) [42] CTT + ++ + + +
Diabetes Empowerment Scale version 2 (Diabetes patients) Shiu et al. (2003) [39] CTT + 0 ++ + + +
Diabetes Empowerment Scale version 2 (Diabetes patients) Shiu et al. (2006) [40] CTT + + +
Diabetes Empowerment Scale version 3 (Diabetes patients) Leksell et al. (2007) [38] CTT + 0 + 0 0
Chinese Diabetes Empowerment Process Scale (Diabetes
patients)
Chen et al. (2011) [43] CTT + + + + 0
Patient Empowerment Scale (Cancer patients) Bulsara et al. (2006) [17] IRT + 0 + +
Cyber Info-Decisional Empowerment Scale (Cancer patients) Seckin (2011) [53] CTT + + +
Genetic Counseling Outcome Scale (Clinical Genetics
patients)
McAllister et al. (2011) [18] CTT 0 + ++ +
+
0 +
Parents’ Postnatal Sense of Security (Postnatal patients) Persson et al. (2007) [48] CTT + + +
Psoriasis Empowerment Enquiry in the Routine practice
(Psoriasis patients)
Pagliarello et al. (2010) [50] CTT + 0 +
The Swedish Rheumatic Disease Empowerment Scale
(Rheumatology patients)
Arvidsson et al. (2012) [51] CTT + 0 + +
COSMIN psychometric property boxes: A = internal consistency, B = reliability, C = measurement error, D = content validity, E = structural validity,
F = hypothesis testing, G = cross-cultural validity, I = responsiveness. 4-point scale rating: +++ = excellent, ++ = good, + = fair, 0 = poor, empty
space = COSMIN rating not applicable. IRT = item response theory; CTT = classical test theory.
doi:10.1371/journal.pone.0126553.t004
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[13,16,37,38,43,47,52,53]; some studies did not report the sampling method at all
[17,28,31,36,46,51] and only a few studies used randomised sampling [39,40,42].
5. Quality of instruments
The assessment of the quality of psychometric properties of included measures using the crite-
ria developed by Terwee et al [23] is summarised in Table 5. It shows that content validity was
assessed in 21 studies and received mainly positive or intermediate ratings. The Empowerment
Scale was tested in five studies with only one of them testing content validity, assessed to be in-
termediate [36]. Internal consistency was tested in all but three studies [31,33,36], with mainly
intermediate and positive ratings. Similarly, 24 studies reported on construct validity, with
only a few negative ratings [35,37,38,51]. No information was found in any study on agree-
ment. Only six studies assessed reliability, resulting in either intermediate [32,37] or positive
[18,36,39,43] scores. Responsiveness, which was assessed in one study, received an intermedi-
ate score [18]. Information on floor and ceiling effects was reported in nine studies, resulting
mainly in intermediate scores [28,37,41,46,47,52]. About half of the studies reported results
that allowed rating of interpretability, and earned mainly intermediate scores
[28,29,31,37,38,40,41,46,47,50–53]. The best performing measure identified in this study was
the Chinese Diabetes Empowerment Process Scale, receiving positive scores for the four psy-
chometric properties assessed. Content validity, internal consistency and construct validity
were the most commonly investigated psychometric properties and results indicated interme-
diate to positive ratings. The psychometric property reproducibility (agreement) was
never assessed.
Discussion
1. Contribution
Many PROMs have been developed to capture patient empowerment but when examined
closely there is a diversity of definitions of patient empowerment captured by these measures.
No two PROMs capture the same construct(s) of patient empowerment and existing tools have
limited overlap in constructs captured. As a result, measurement of patient empowerment suf-
fers from a lack of clarity and consensus about core constructs. Furthermore, the scientific
quality of most instruments is low. Thirty studies were identified assessing 19 measures of pa-
tient empowerment that could be used as PROMs, the earliest of which was published in 1999.
In comparison to the Herbert et al review [19], the present review identified 21 new studies,
with 15 new measures of patient empowerment, and added robust quality appraisal of included
studies and measures using published quality criteria. Furthermore, the present study has clas-
sified the constructs captured by patient empowerment measures into four domains, support-
ing previous work suggesting that patient empowerment can be conceived of as a concept that
is related to, but broader than patient-centeredness [54]. Patient empowerment can be concep-
tualised as a process achieved through patient-centered care, or as an outcome, and includes el-
ements relating to both patient and healthcare professional roles, shared decision-making,
patient self-efficacy and coping [54,55]. Constructs identified in domain 1 (patient states, expe-
riences and capacities e.g. perceived control) and domain 2 (patient actions and behaviours e.g.
health-directed behaviour) could be conceived of as patient outcomes from use of patient-cen-
tred healthcare. Constructs identified in domain 3 (patient self-determination within the
healthcare relationship e.g. power-sharing and collaboration) and domain 4 (patient skills de-
velopment) could be conceived of as the process through which patient and provider collabo-
rate to achieve those outcomes [56].
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Table 5. Quality of psychometric properties (Terwee ratings).
Measure (target
population)
Authors
(Year)
Content
validity
Internal
consistency
Construct
validity
Agreement Reliability Responsiveness Floor &
ceiling
effects
Interpretability
Patient
Empowerment
Scale (All
patients, generic)
Faulkner
(2001) [13]
+ - 0 0 0 0 0 0
Kim Alliance
Scale (All
patients, generic)
Kim et al.
(2001) [46]
+ ? + 0 0 0 ? ?
Kim Alliance
Scale (Revised)
(All patients,
generic)
Kim et al.
(2008) [47]
+ + + 0 0 0 ? ?
Treatment-
Related
Empowerment
Scale (All
patients, generic)
Webb et al.
(2001) [45]
? ? + 0 0 0 0 0
Health Education
Impact
Questionnaire (All
patients, generic)
Osborne et al.
(2007) [44]
+ + 0 0 0 0 0 0
No Name (Scale
developed by
Bann et al) (All
patients, generic)
Bann et al.
(2010) [49]
+ + ? 0 0 0 - 0
Health Care
Empowerment
Inventory (All
patients, generic)
Johnson et al.
(2012) [52]
0 ? + 0 0 0 ? ?
Empowerment
Scale version 1
(Mental health
patients)
Wowra &
McCarter
(1999) [29]
0 + ? 0 0 0 0 ?
Empowerment
Scale version 1
(Mental health
patients)
Hansson &
Bjorkman
(2005) [28]
? - + 0 0 0 ? ?
Empowerment
Scale version 1
(Mental health
patients)
Yamada &
Kuzuki (2007)
[31]
0 0 ? 0 0 0 0 ?
Empowerment
Scale version 1
(Mental health
patients)
Rogers et al.
(2010) [30]
0 - ? 0 0 0 0 0
Empowerment
Scale version 2
(Mental health
patients)
Corrigan et al.
(1999) [36]
0 0 ? 0 + 0 0 0
Health Promotion
Intervention
Questionnaire
(Mental health
patients)
Svedberg
et al. (2007)
[33]
0 0 + 0 0 0 0 0
(Continued)
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Table 5. (Continued)
Measure (target
population)
Authors
(Year)
Content
validity
Internal
consistency
Construct
validity
Agreement Reliability Responsiveness Floor &
ceiling
effects
Interpretability
Health Promotion
Intervention
Questionnaire
(Mental health
patients)
Svedberg
et al. (2008)
[32]
? + ? 0 ? 0 0 +
Empowerment
Questionnaire for
Inpatients (Mental
health patients)
Lopez et al.
(2010) [37]
+ ? - 0 ? 0 ? ?
Consumer
Evaluation Of
Mental Health
Services (Mental
health patients)
Oades et al.
(2011) [34]
+ ? 0 0 0 0 0 0
Inpatient
Consumer
Survey (Mental
health patients)
Ortiz &
Schacht
(2012) [35]
+ + - 0 0 0 0 0
Diabetes
Empowerment
Scale version 1
(Diabetes
patients)
Anderson
et al. (2000)
[16]
- + ? 0 0 0 0 0
Diabetes
Empowerment
Scale version 1
(Diabetes
patients)
Sigurdardottir
& Jonsdottir
(2008) [41]
+ + + 0 0 0 ? ?
Diabetes
Empowerment
Scale version 1
(Diabetes
patients)
Tol et al.
(2012) [42]
? ? ? 0 0 0 0 0
Diabetes
Empowerment
Scale version 2
(Diabetes
patients)
Shiu et al.
(2003) [39]
+ + ? 0 + 0 0 0
Diabetes
Empowerment
Scale version 2
(Diabetes
patients)
Shiu et al.
(2006) [40]
0 + ? 0 0 0 0 ?
Diabetes
Empowerment
Scale version 3
(Diabetes
patients)
Leksell et al.
(2007) [38]
0 - - 0 0 0 + ?
Chinese Diabetes
Empowerment
Process Scale
(Diabetes
patients)
Chen et al.
(2011) [43]
+ + + 0 + 0 0 0
(Continued)
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Measures identified by Herbert et al. captured constructs ranging from psychological
empowerment (interpersonal, interactional, behavioral), through knowledge, skills and atti-
tudes, to decision-making, sense of control, hope, coping and self-efficacy. All of these con-
structs could be identified in measures included in the present study, with additional
dimensions captured by some of the newer measures e.g. acceptance [17], emotional wellbeing/
regulation [18,44], tolerance of uncertainty [52], stigma [34] and sense of affinity with the fam-
ily [48]. There is also some cultural diversity identifiable with stress management included only
in Swedish measures, and some constructs that may be specific to the mental health context.
This variation appears to reflect lack of clear conceptualisation of patient empowerment. While
there is some overlap across these constructs, the heterogeneity of terms used to describe pa-
tient empowerment appears to be increasing with time and is not helpful for measurement.
This also limits the comparability of findings across surveys as different measures capture dif-
ferent aspects of patient empowerment, based upon their different conceptual underpinnings.
The variation in constructs captured by patient empowerment questionnaires has been noted
previously [12,19], yet members of this team were surprised at the extent of variation when
limiting this review to focus only on instruments that aim to measure patient empowerment.
Without conceptual clarity of what patient empowerment is, measurement tools will inevitably
Table 5. (Continued)
Measure (target
population)
Authors
(Year)
Content
validity
Internal
consistency
Construct
validity
Agreement Reliability Responsiveness Floor &
ceiling
effects
Interpretability
Patient
Empowerment
Scale (Cancer
patients)
Bulsara et al.
(2006) [17]
+ ? 0 0 0 0 0 0
Cyber Info-
Decisional
Questionnaire
(Cancer patients)
Seckin (2011)
[53]
0 + ? 0 0 0 0 ?
Genetic
Counseling
Outcome Scale
(Clinical Genetics
patients)
McAllister
et al. (2011)
[18]
+ ? ? 0 + ? 0 0
Parents‘
Postnatal Sense
of Security
(Postnatal Care
patients)
Persson et al.
(2007) [48]
? ? 0 0 0 0 0 0
Psoriasis
Empowerment
Enquiry in the
Routine practice
(Psoriasis
patients)
Pagliarello
et al. (2010)
[50]
+ - 0 0 0 0 0 ?
The Swedish
Rheumatic
Disease
Empowerment
Scale
(Rheumatology
patients)
Arvidsson
et al. (2012)
[51]
+ - - 0 0 0 - ?
Rating: + = positive, ? = intermediate, - = negative, 0 = no information available.
doi:10.1371/journal.pone.0126553.t005
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vary and choosing tools to assess patient empowerment either as a process or outcome will
be difficult.
There is considerable overlap between the constructs captured in the measures identified in
this review and constructs captured by other measures not purporting to be measures of patient
empowerment, such as enablement, activation, shared decision-making and capability. The Pa-
tient Enablement Instrument focuses on whether patients feel able to understand their illness,
cope with their illness and their lives, and keep themselves healthy [57]. The Patient Activation
Measure (PAM) [58] is based on a developmental model, capturing patient development across
four stages: (1) believing the patient role is important, (2) having the confidence and knowledge
necessary to take action, (3) actually taking action to maintain and improve one’s health, and
(4) staying the course even under stress [58]. Both enablement and activation overlap with
some, but not all constructs across the four domains identified in the current study. However,
they may not adequately capture all dimensions of patient empowerment.
Other areas of cross over with patient empowerment include measures of shared decision-
making, which may capture aspects of collaboration and mutual decision-making, components
of domain 3 in our categorisation of patient empowerment [59,60]. The ICECAP capability
[61,62] measures capture patient wellbeing defined in terms of ability to 'do' and 'be' the impor-
tant things in life: enjoyment, achievement and attachment and is a more general measure of
patient quality of life. There are also a number of measures available to capture self-efficacy,
perceived control and other constructs captured by measures identified in the current study
[63,64]. Some or all of these may be better quality measures in respect of their psychometric
properties, but a full review of these is outside the scope of the present review which focused on
measures purporting to capture patient empowerment.
The quality of included studies was found to be poor to fair, with many psychometric prop-
erties of instruments untested. Where these properties were tested, there was limited evidence
to support reliability and validity of existing measures. Some elements of COSMIN may not be
applicable to all studies, for example only five of 30 studies were assessed for cross-cultural va-
lidity, as they had translated a measure from the original language. However, it is of some con-
siderable concern that few studies investigated measurement error, reliability, criterion validity
and responsiveness. Of particular concern is the lack of reliability assessment, as there can be
no validity of measurement without reliability. When assessing reliability it is recommended
that both internal consistency and test-retest reliability be investigated [65]. We found that
many authors used internal consistency as the sole indication of reliability; this is an inadequate
assessment of reliability [65].
From a policy and practice standpoint, for a measure to be useful as a PROM for evaluating
interventions, it is vital to understand how responsive the measure is to change in the underly-
ing construct being measured e.g. use of a decision support tool to promote patient empower-
ment. However, only one measure identified in this review was assessed for responsiveness, the
Genetic Counseling Outcome Scale [18], which received an intermediate rating. It is also perti-
nent to have some indication of the minimal important change (MIC) or minimal important
difference (MID) in scores on the measure (COSMIN v9). Without such insight, it is not possi-
ble to understand whether changes in levels of patient empowerment matter to patients. No
study included in the present review assessed the MID or MIC of the measure
under investigation.
The World Health Organisation [1] called for better measures of patient empowerment in
2006. However, although the three most commonly assessed psychometric properties of the
measures identified in this review (content validity, internal consistency and construct validity)
earned intermediate to positive ratings, other important properties, notably reliability and re-
sponsiveness were not assessed for most measures. No study assessed all the psychometric
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properties highlighted by Terwee et al [23]. Without full assessment of psychometric proper-
ties, the validity and reliability of results generated by use of that measure are questionable. An-
other significant concern was the variation in quality of the psychometric properties of the
same measure when assessed across different studies. For example internal consistency of the
Empowerment Scale earned a rating of ‘positive’ in one study [29], ‘intermediate’ in second
study [31] and ‘poor’ in two other studies [28,30].
The findings of limited psychometric quality of the 19 questionnaires identified in this
study designed to capture patient empowerment is similar to that found in the Herbert system-
atic review [19] of measures of health-related empowerment. Interestingly test-retest reliability
was assessed in five of the 50 studies identified by Herbert et al [19] and only one of 50 studies
reported good evidence of validity and reliability for the measures under investigation. Of
those, only four had moderate support. The challenges facing the field of patient empowerment
are similar to those in related fields, such as shared decision-making [59,60] and decisional re-
gret [66], where lack of conceptual clarity and limited evidence of reliability and validity of
measures are well-documented. These constructs are similar in that they are not directly ob-
servable (latent), multidimensional and most importantly, are related to patients and their im-
portant, but subjective perceptions.
2. Strengths and limitations
This is the first systematic review of measures of patient empowerment to apply published
quality criteria, assessing both the methodological quality of the studies and the psychometric
properties of the measures identified. This review enables researchers and clinicians to view at
a glance the strengths and limitations of existing measures of patient empowerment that could
be used as PROMs in terms of constructs captured and psychometric properties. Despite the
strengths of the review, there are some limitations. Firstly the method deviated from the proto-
col when a decision was made to exclude measures of enablement, activation, perceived con-
trol, capability and independence and to focus only on measures that aim to capture patient
empowerment. However, a review of the 102 articles identified that included those reporting
measures capturing these other five constructs would not have included all measures that cap-
ture similar / overlapping constructs (e.g. all measures of self-efficacy). Limiting the review to
measures purporting to capture patient empowerment enabled a clear focus on patient empow-
erment to develop understanding of how this construct has been operationalised in measures
purporting to capture it as well as establishing the quality of these measures, while removing
the ambiguity of including measures of related, but subtly different constructs. As with any sys-
tematic review, there is a lag between the time of the search completion and the final manu-
script publication; therefore it is possible that we may have missed more recent literature. For
example, a recently developed new measure of empowerment for use in long-term conditions
was developed by Small et al [14]. This measure captured a construct of empowerment com-
prising positive attitude and sense of control, knowledge and confidence in decision making
and enabling others. Psychometric testing was limited to assessment of structural validity, in-
ternal consistency and hypothesis testing, with no assessment of either test-retest reliability
or responsiveness.
3. Implications for future research
This systematic review adds to the findings of Herbert et al [19] and highlights the need for a
definitive measure of patient empowerment. Despite policy interest and initiatives relating to
patient empowerment, there is limited evidence to support the reliability and validity of exist-
ing tools. Future research could usefully develop a definitive generic measure of patient
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empowerment—one that is valid, reliable and sensitive to changes important to patients and
other stakeholders, for use across healthcare systems to enable comparability of results.
This systematic review belongs mainly in the positivist tradition, incorporating a partly con-
structivist approach, recognising multiple interpretations, in the analysis of constructs captured
by the included measures. We believe that moving forward, a combination of constructivist
and critical realist positions will be most productive in patient empowerment research. This ap-
proach would be in keeping both with (1) ensuring development of a construct to operationa-
lise in the new measure that has consensual support amongst key stakeholders and with (2) the
emerging ‘realist’ approach to evaluating complex social interventions or programmes, which
focuses on establishing what works for whom and how this can best be achieved [67]. This ap-
proach reflects a belief that patient empowerment does have an underlying structure that could
be partly revealed through (constructivist) Qualitative Item Review (QIR) [68] of items cap-
tured in measures of patient empowerment identified in the current review, supplemented by
(constructivist) qualitative research with patients and a (constructivist/realist) consensus exer-
cise amongst stakeholders, soliciting views from patients, health providers and healthcare poli-
cy makers. This epistemological shift would make it possible to develop a valid measure of
patient empowerment that captures a construct that is plausible and important to a range of
stakeholders. The constructs identified in the present review as captured by at least two mea-
sures provide a useful starting point for this work.
4. Conclusions
This study has identified significant effort over the last 25 years to develop innovative measures
that aim to capture patient empowerment. This reflects a surge of interest in the idea of em-
powering patients, and of measuring the degree to which this can be demonstrated. However,
the review has highlighted significant shortcomings of available measures of patient empower-
ment, particularly for use as PROMs in evaluating healthcare policies and interventions. Avail-
able measures capture a diversity of constructs and have very limited evidence of two
psychometric properties that are vital for PROMs, reliability and responsiveness, and no avail-
able measures have been tested for MID or MIC, also very important for any measure that is to
be used as a PROM. This study contributes significant clarification of how patient empower-
ment, as operationalised in measures purporting to capture this concept, overlaps with, and
differs from other related constructs. More research is needed to develop a clear definition of
patient empowerment that could be operationalised to create a definitive, valid, reliable and re-
sponsive measure of patient empowerment. A definitive PROM capturing patient empower-
ment would enable healthcare interventions and policies designed to empower patients to be
evaluated on the basis of how effective they are at achieving that goal.
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